IndraLab

Statements


USP37 deubiquitinates oncogenic fusion PLZF-RARA. 1 / 1
| 1

reach
"Lastly, USP37 deubiquitinates and stabilizes the proto-oncogene c-Myc and the oncogenic fusion PLZF-RARA, suggesting that inhibition of USP37 DUB activity could have therapeutic potential XREF_BIBR, XREF_BIBR."